Attributes | Values |
---|
rdf:type
| |
Description
| - Genetic variation of cytomegalovirus (CMV) strains can correlate with their pathogenicity for immunocompromised patients. Glycoprotein O (gO), together with glycoprotein L and glycoprotein H, mediate the fusion of the viral envelope with the cell membrane and promotes virus penetration, envelopment, and release. The variability of gO might play a role in CMV cell tropism. The goal was a retrospective analysis of gO variability in a cohort of hematopoietic stem cell transplant (HSCT) recipients to determine the distribution of gO genotypes and to investigate their impact on clinical outcome and manifestation of CMV infection. gO genotyping may contribute to the biological characterization of CMV strains in HSCT recipients.
- Genetic variation of cytomegalovirus (CMV) strains can correlate with their pathogenicity for immunocompromised patients. Glycoprotein O (gO), together with glycoprotein L and glycoprotein H, mediate the fusion of the viral envelope with the cell membrane and promotes virus penetration, envelopment, and release. The variability of gO might play a role in CMV cell tropism. The goal was a retrospective analysis of gO variability in a cohort of hematopoietic stem cell transplant (HSCT) recipients to determine the distribution of gO genotypes and to investigate their impact on clinical outcome and manifestation of CMV infection. gO genotyping may contribute to the biological characterization of CMV strains in HSCT recipients. (en)
|
Title
| - Genetic variability of cytomegalovirus glycoprotein O in hematopoietic stem cell transplant recipients
- Genetic variability of cytomegalovirus glycoprotein O in hematopoietic stem cell transplant recipients (en)
|
skos:prefLabel
| - Genetic variability of cytomegalovirus glycoprotein O in hematopoietic stem cell transplant recipients
- Genetic variability of cytomegalovirus glycoprotein O in hematopoietic stem cell transplant recipients (en)
|
skos:notation
| - RIV/75010330:_____/11:00009081!RIV13-MZ0-75010330
|
http://linked.open...avai/predkladatel
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(NR9418), Z(MZ0UHKT2005)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/75010330:_____/11:00009081
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - cytomegalovirus; CMV; genotypes; transplantation; stem cells (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Transplant infectious disease
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Procházka, Bohumír
- Roubalová, K.
- Strunecký, Otakar
- Vítek, A.
- Žufanová, Světlana
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://bibframe.org/vocab/doi
| - 10.1111/j.1399-3062.2011.00625.x
|
is http://linked.open...avai/riv/vysledek
of | |